- Home
- NICE vs VRNA Comparison
NICE vs VRNA Comparison
Compare NICE & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NICE
- VRNA
- Stock Information
- Founded
- NICE 1986
- VRNA 2005
- Country
- NICE Israel
- VRNA United Kingdom
- Employees
- NICE N/A
- VRNA N/A
- Industry
- NICE Computer Software: Prepackaged Software
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- NICE Technology
- VRNA Health Care
- Exchange
- NICE Nasdaq
- VRNA Nasdaq
- Market Cap
- NICE 8.6B
- VRNA 8.3B
- IPO Year
- NICE 1996
- VRNA 2017
- Fundamental
- Price
- NICE $135.34
- VRNA $106.91
- Analyst Decision
- NICE Buy
- VRNA Buy
- Analyst Count
- NICE 13
- VRNA 11
- Target Price
- NICE $204.46
- VRNA $114.10
- AVG Volume (30 Days)
- NICE 528.8K
- VRNA 1.5M
- Earning Date
- NICE 11-13-2025
- VRNA 11-03-2025
- Dividend Yield
- NICE N/A
- VRNA N/A
- EPS Growth
- NICE 39.25
- VRNA N/A
- EPS
- NICE 8.36
- VRNA N/A
- Revenue
- NICE $2,838,467,000.00
- VRNA $221,673,000.00
- Revenue This Year
- NICE $9.20
- VRNA $909.96
- Revenue Next Year
- NICE $6.96
- VRNA $76.47
- P/E Ratio
- NICE $16.17
- VRNA N/A
- Revenue Growth
- NICE 11.39
- VRNA N/A
- 52 Week Low
- NICE $127.00
- VRNA $31.09
- 52 Week High
- NICE $200.65
- VRNA $106.94
- Technical
- Relative Strength Index (RSI)
- NICE 37.24
- VRNA 72.60
- Support Level
- NICE $137.48
- VRNA $105.78
- Resistance Level
- NICE $141.10
- VRNA $106.86
- Average True Range (ATR)
- NICE 3.81
- VRNA 0.16
- MACD
- NICE -1.07
- VRNA -0.04
- Stochastic Oscillator
- NICE 8.06
- VRNA 98.26
About NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.